Research

Technavio released its latest report, which states that the CBD skincare market value is set to grow by $1.64 billion, progressing at a CAGR of 33% from 2019 to 2024. The market is segmented by type (oils, CMC and MSL), source (hemp and marijuana) and geography (North America, Europe, Asia-Pacific, South America, and the Middle East…

CBD-dedicated online resource Leafreport conducted an analysis of the pricing of different CBD brands and products. Every six months Leafreport captures a snapshot of the CBD market. It carries out an in-depth pricing analysis, collecting data to compare the prices of more than 3,000 CBD products from more than 100 brands. Its CBD price reports…

A six-month, randomized clinical trial studying the effects of cannabidiol (CBD) on menstrual-related symptoms by Canopy Growth Corp.’s scientific research team yielded positive results. This study was conducted in collaboration with Dr. Jessica G. Irons and Morgan L. Ferretti at James Madison University in Harrisonburg, Va. Nearly 75% of reproductive-aged menstruating individuals report experiencing unpleasant…

  Health Canada approved the amendment of a phase I study conducted in collaboration by leading cannabinoid-derived drug discovery and development company Tetra Bio-Pharma Inc. and Dr. Jutras-Aswad and the University of Montreal Hospital Research Centre. The study will assess the safety profile of low and moderate doses of inhaled CBD and determine the cognitive,…

Radicle Science, a healthtech B corporation specializing in validating health and wellness products, will launch what’s being called the first large-scale, blinded, placebo-controlled clinical trials on rare cannabinoids, including THCV, CBN, CBG and CBC. The trials – dubbed Radicle Discovery – will study those cannabinoids’ effects on energy, focus, appetite, sleep disturbance, pain, stress and…

CBD industry peer-reviewed watchdog website Leafreport.com announced recently the launch of four calculators designed to help consumers determine whether their CBD products’ content matches their labels, discover their individualized dosage of CBD and decide whether the products they are buying are worth the price based upon CBD potency. The newly launched calculators serve as tools…

Brains Bioceutical Corp. announced the initiation of a clinical trial, using an EU-GMP grade CBD API from its wholly-owned subsidiary BSPG Laboratories. As part of this study initiation, the Icahn School of Medicine at Mount Sinai in New York is initiating the PK study with Brains Bio’s oral drug formulation of CBD in a hard…

CBD is quickly growing in popularity, and many retailers are adding these products to their shelves, from tinctures to gummies to supplements and more. But not all CBD is made equal. Retailers are wise to keep track of which types of CBD most resonate with consumers. According to market research firm Brightfield Group, full-spectrum is…

The National Football League (NFL) has granted $1 million in research funding to two teams of medical researchers at the University of California San Diego and University of Regina to investigate the effects of cannabinoids on pain management and neuroprotection from concussion in “elite football players.” “As with the league’s broader approach to health and…

According to Financial News Media, Brightfield Group recently released a report on the sales of CBD in the United States that shows sales of CBD reached $4.7 billion in 2021, an increase of 15% over sales in 2020. The pandemic constrained CBD growth, with brands losing revenue from store closures, but a strong e-commerce presence…

The Emerald Conference, curated by the Emerald Conference’s Scientific Committee and produced by MJBizScience, will return in person on Feb. 27-March 1 to the Loews Coronado Bay Resort in San Diego. The Emerald Conference is the original, longest-running interdisciplinary cannabis science event. Acquired by MJBiz in early 2020, the two-day conference has become the must-attend…

Delta-8 THC arrived on the market around December 2020. Its unique effects gained attention from consumers and retailers alike. But it’s not the only minor cannabinoid out there. From CBN and CBG to delta-8, delta-10, and THCv, innovations with minor cannabinoids are just getting started. Market research firm Brightfield Group data shows cannabis consumers are…

According to a new study called “Cannabidiol and the anti-viral response to SARS-CoV-2 proteins,” synthetic cannabidiol (CBD) “appears to prime the innate immune system of cells, potentially offering protection against pathogens such as SARS-CoV-2,” or COVID-19. The study, which was co-authored by Duncan, Fernandes, John Zewen Chan, Chia Chun Joey Hung and Michelle Tomczewski of…

The cannabis industry in the U.S. could reach $45.8 billion by 2025 with compound annual growth rates (CAGR) between 2-8% annually, according to Headset, a cannabis industry data and analytics firm. “The opportunities presented in the U.S. cannabis market have been consistently increasing year over year since the inaugural states of Colorado and Washington voted…

The CBD skincare market is expected to hit $3.4 billion globally by 2026, with a compound annual growth rate (CAGR) of 24.8% during the forecast period, according to a report from Allied Market Research. For comparison, the market was valued at just $633.6 million in 2018. Growth will likely be attributed to the rapid rise…

Among the results of a new study by healthtech B-corp Radicle Science, participants experienced a 71% improvement in their well-being on average. Thirteen U.S. brands were included in the four-week Radicle Advancing CBD Education and Science (ACES) study, which set out to determine whether botanical products with CBD deliver therapeutic benefits across five health outcomes,…

New data from market research company Brightfield Group confirms 2021 has been a positive year for the cannabis industry, with new U.S. states legalizing the substance, plus other countries across the world considering cannabis reform, from Mexico to Germany. Thanks to the industry’s growth and the effects of the pandemic, Brightfield Group is outlining opportunities…

A new study published in the Journal of Clinical Psychopharmacology found that cannabidiol (CBD) can lessen the psychoactive effects of d9-tetrahydrocannabinol (THC) when taken together.  The goal of the study — by researchers Jose’ Bouso, PhD from the International Center for Ethnobotanical Education, Research and Service, and Alberto Sainz-Cort, MSc from Universitat Oberta de Catalunya…

Cannabidiol (CBD) sales in the convenience and petroleum channel are set to hit $171 million in 2021 — up 49% from 2020, according to market research firm Brightfield Group’s “US CBD Market Industry Update, October 2021.” The market is forecast to reach $449 million by 2026, representing a 21% compound annual growth rate (CAGR) from…

According to a new report by market research firm Brightfield Group, the U.S. hemp-derived CBD market is expected to reach $4.7 billion in retail sales in 2021, an increase of 2.5% from 2020 sales of $4.6 billion. Sales are expected to reach $12.0 billion by 2026, driven by accelerated growth of ingestibles like drinks (40%…

LEVEL, a science-driven cannabis company, and Curebase, a company committed to democratizing access to clinical studies, announced a decentralized clinical study to determine whether cannabis can have a positive impact on sleep quality for U.S. Veterans. LEVEL is pleased to co-sponsor this study with the Veterans Cannabis Group to identify and recruit participants for this…

Preliminary results from a new study on the effects of CBD oil on golf players have shown positive effects on injury, sleep and on-course golf performance. The study, a joint operation with quantitative insight produced by a sport specialist market research consultancy Sports Marketing Surveys (SMS) supported by shot tracking data from Shot Scope, combines interviews…

Adults 18-34 years old use cannabidiol (CBD) or cannabis to treat chronic pain at two times the rate of people who are 45 or older, according to a new survey by the Harris Poll on behalf of the Samueli Foundation. The survey shows that those ages 18-34 years are more likely to experience chronic pain,…

According to a CivicScience study of more than 40,000 of-age Americans (21 and older), 34% of respondents said they have had some experience with various CBD products, and 15% intend to give them a try soon, totaling nearly half of the of-age general population. So, what is driving CBD sales and overall interest? As the…

Cannabidiol (CBD) products are becoming ubiquitous: from the gummies at customers’ local c-store to the CBD-laced peanut butter they considered buying online for their pets. It’s an increasingly prevalent trend that has wafted into dozens of industries and grown abundantly on retail shelves and online storefronts alike. In fact, in a recent CivicScience study of…